Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases
Disease Category: Pulmonary Arterial Hypertension

Trial Information

Pulmonary Hypertension Study CQTI571A2301

Novartis is conducting this clinical trial to determine the benefits and safety of a Novartis investigational drug as an add-on therapy in the treatment of people with severe pulmonary arterial hypertension (PH).
An ?investigational drug? is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).
Participants will be asked to visit the study center over a 6 month period.
www.NovartisClinicalTrials.com

Research Center
Located In:
Various Cities, OR

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.